Electronic cigarette smoking exerts unfavourable effect just like tobacco cigarette smoking

21-6-2016 • Vlachopoulos C et al. JACC 2016
Research letter shows that smoking of an electronic cigarette affects BP and aortic stiffness to a similar extent as does tobacco cigarette smoking. Read more

Statin treatment effective and safe in very young HeFH subjects

20-6-2016 • Langslet G et al., J Clin Lipidol. 2016
Open-label prospective 3-year study of atorvastatine in HeFH subjects aged 6-15 years showed that treatment was safe, effective and did not affect growth or maturation. Read more

Maternal and pregnancy factors affect risk of future T2DM in women with gestational diabetes

20-6-2016 • Rayanagoudar G et al., Diabetologia 2016
Several maternal and pregnancy factors are associated with a higher risk of developing T2DM in women with gestation diabetes. They can be used for personal risk quantification. Read more
News • 15-6-2016

EHRA practical guide for non-vitamin K antagonist anticoagulants in non-valvular AF patients updated

The European Heart Rhythm Association (EHRA) published a rewritten, updated version of the previously published (2013) guidelines for NOACs in non-valvular AF patients. Read more
News • 15-6-2016

Highest CV mortality risk for T2DM patients previously hospitalised with heart failure

ADA 2016 Evaluation CV mortality risk for 5380 EXAMINE patients with T2DM on alogliptin/placebo, showed that risk for patients experiencing a non-fatal CV was especially increased for HHF patients. Read more

Higher risk of hypertension associated with exposure to air pollutants

10-6-2016 • Cai Y et al., Hypertension. 2016
In a systematic review and meta-analysis of 17 studies, the short-term and long-term exposure to air pollutants was significantly associated with increased risk for hypertension. Read more
News • 21-6-2016

EPCCS consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care

General practitioners representing various European countries discussed recent developments in the SPAF field, and specific implications for primary care in an expert meeting. This meeting resulted in a practical guidance for European GPs. Read more

HF diagnosis often unjustified in primary care

20-6-2016 • Valk MJ et al., BJGP 2016
An expert panel that retrospectively identified HF patients according to ESC guidelines could not confirm one-third of the cases that were HF-diagnosed by the general practitioner. Read more

CV event reduction with GLP-1 analogue in patients with type 2 diabetes

16-6-2016 • Marso SP et al., N Engl J Med 2016
ADA 2016 In T2DM patients at high CV risk, liraglutide on top of standard therapy was associated with lower rates of CV events and mortality, compared with placebo in the LEADER outcome trial. Read more
News • 15-6-2016

Lower blood sugar with DPP-4 inhibitor in adults with type 2 diabetes at risk for renal impairment

ADA 2016 In 360 patients with T2DM and albuminuria, linagliptin significantly reduced blood glucose levels, is well tolerated and does not need dose adjustment in patients at risk for kidney impairment. Read more
News • 15-6-2016

All age groups have CV benefit from SGLT2 inhibition in type 2 diabetes

ADA 2016 New empagliflozin data show that reduced risk for cardiovascular death was consistent across age groups in adults with type 2 diabetes. Read more

Cardiac function and structure improved by vitamin D supplementation in heart failure patients

9-6-2016 • Witte KK, et al. J Am Coll Cardiol 2016
In patients with chronic HF and vitamin D deficiency, high-dose vitamin D3 supplementation is safe, well tolerated, and associated with a favourable effect on cardiac function and structure. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
EPCCS 2013 Report of 6th Annual EPCCS meeting held in London
EPCCS 2012 Report of 5th Annual EPCCS meeting held in Athens
All meeting reports...